Although coronaviruses were first identified nearly 60 years ago, they only received notoriety
in 2003 when one of their members was identified as the aetiological agent of severe acute …

Infection of humans with the severe acute respiratory syndrome coronavirus (SARS-CoV)
results in substantial morbidity and mortality, with death resulting primarily from respiratory …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is causing a
global pandemic, and cases continue to rise. Most infected individuals experience mildly …

Studies of patients with severe acute respiratory syndrome (SARS) demonstrate that the
respiratory tract is a major site of SARS-coronavirus (CoV) infection and disease morbidity. We …

The severe acute respiratory syndrome (SARS), caused by a novel coronavirus (SARS-CoV),
resulted in substantial morbidity, mortality, and economic losses during the 2003 epidemic. …

The severe acute respiratory syndrome coronavirus (SARS-CoV) caused substantial morbidity
and mortality in 2002–2003. Deletion of the envelope (E) protein modestly diminished …

Humoral immunity to SARS-CoV-2 can be supplemented with polyclonal sera from convalescent
donors or an engineered monoclonal antibody (mAb) product. While pentameric IgM …

The RIG-I-like receptors (RLRs) signal innate immune defenses upon RNA virus infection,
but their roles in adaptive immunity have not been clearly defined. Here, we showed that the …

This study explores in an adolescent sample hypotheses about child sexual abuse perpetration
drawn from contemporary theories that implicate insecure attachment and adolescent …

Most animal species that can be infected with the severe acute respiratory syndrome-associated
coronavirus (SARS-CoV) do not reproducibly develop clinical disease, hindering …